Efficacy and Safety of High-Dose Mizoribine Combined With Cyclosporine, Basiliximab, and Corticosteroids in Renal Transplantation: A Japanese Multicenter Study
Author:
Publisher
Elsevier BV
Subject
Transplantation,Surgery
Reference9 articles.
1. Studies on bredinin. I. Isolation, characterization and biological properties;Mizuno;J Antibiot,1974
2. Mizoribine and mycophenolate mofetil;Ishikawa;Curr Med Chem,1999
3. Mizoribine in combination therapy with tacrolimus for living donor renal transplantation;Akiyama;Transplant Proc,2005
4. Excellent results with high-dose mizoribine combined with cyclosporine, corticosteroid, and basiliximab in renal transplant recipients: multicenter study in Japan;Nishimura;Transplant Proc,2012
5. No myelosuppression when mizoribine is combined with allopurinol for the treatment of hyperuricemia in renal transplant patients;Jain;Clin Exp Nephrol,2001
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Acute renal failure after kidney transplantation due to mizoribine-induced ureteral stones;BMC Nephrology;2024-01-03
2. The Efficacy and Safety of Mizoribine versus Mycophenolate Mofetil for the Treatment of Renal Transplantation: A Systematic Review and Meta-Analysis;Computational Intelligence and Neuroscience;2022-07-22
3. Conversion from mycophenolate mofetil to mizoribine in the early stages of BK polyomavirus infection could improve kidney allograft prognosis: a single-center study from China;BMC Nephrology;2021-10-02
4. Acute and severe ribavirin-associated hyperuricemia and acute kidney injury: An underrecognized adverse effect;American Journal of Health-System Pharmacy;2021-02-22
5. Comparative Study of Mizoribine and Mycophenolate Mofetil Combined with a Calcineurin Inhibitor-Based Immunosuppressive Regimen in Patients with Alternative Donor Hematopoietic Cell Transplantation;Biology of Blood and Marrow Transplantation;2020-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3